STRO-501

N/A

Report date: 2024/10/10 14:33:48

Base Information

Drug NameSTRO-501
Drug Alias NameSTRO-501
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTransforming Growth Factor, Beta-Induced modulators
TargetsTransforming Growth Factor, Beta-Induced
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStromaCare SAS
China Registration ClassN/A

Develop Information

Active CompaniesStromaCare SAS
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder NeoplasmsOvarian Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A